LobbyingCba Pharma lobbying by quarter
Cba Pharma's latest lobbying report covers Q1 2026, at $10K. The four quarters Q4 2025–Q3 2026 total $20K. Its first report covers Q4 2025; the issues it reports most are Health Issues and Law Enforcement/Crime/Criminal Justice.
Cba Pharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $20K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2025 | $10K | 1 |
| Q1 2026 | $10K | 1 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$10K · 2 reports
- Law enforcement and criminal justice$10K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)2 reports
- Justice, Dept of (DOJ)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Tenagrity Solutions | $20K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JENNY CAROLINE DEBERRY | Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission | Q1 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 04/20for Q1 | Tenagrity Solutions | $10K |
| 01/20for Q4 2025 | Tenagrity Solutions | $10K |
| 01/16for Q4 2025 | Tenagrity Solutions | Under $5,000 |